Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection

World Journal of Gastroenterology

Volumn 8, Issue 6, 2002, Pages 1019-1022

  Fu, Qing Guo ^a   Meng, Fan Dong ^a   Shen, Xiao Dong ^a   Guo, Ren Xuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; FLUOROURACIL; INTERLEUKIN 2; MITOMYCIN C; SODIUM CHLORIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CLASSIFICATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG DOSE REGIMEN; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERTHERMIC THERAPY; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERFUSION; PERITONEAL CAVITY; POSTOPERATIVE CARE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; STATISTICAL ANALYSIS; STOMACH CANCER; TH1 CELL; TREATMENT PLANNING;

EID: 0036900197     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i6.1019     Document Type: Article

References (37)

1. Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-2519
2. Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer 2001; 4: 27-33
3. Witkamp AJ, De Bree E, Kaag MM, Boot H, Beijnen JH, Van Slooten GW, Van Coevorden F, Zoetmulder FA. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37: 979-984
4. Sugarbaker PH, Yonemura Y. Palliation with a glimmer of hope: Management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2001; 48: 1238-1247
5. Elias DM, Ouellet JF. Intraperitoneal chemohyperthermia: Rationale, technique, indications, and results. Surg Oncol Clin N Am 2001; 10: 915-933
6. Chen J, Wang S, Xu H. Curative effect of radical gastrectomy combined with peritoneal lavage with thermal hypoosmotic solution in treatment of gastric cancer. Zhonghua Yixue Zazhi 2001; 81: 730-732
7. Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Sugimachi K. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 2002; 131: S78-84
8. Chen ZX, Chen JP, Chen Z, Peng DS, Zhen JX, Tan JS. Treatment of cancerous ascites and radical gastrectomy with intraperitoneal hyperthermic double distilled water and cis-diaminodichloro-platinum perfusion. China Natl J New Gastroenterol 1997; 3: 246-248
9. Raub B, Gaestel M, Wust P, Stahl J, Mansmann U, Schlag PM, Benndorf R. Preoperative treatment of rectal cancer with radiation, chemotherapy and hyperthermia: Analysis of treatment efficacy and heat-shock response. Radiat Res 1999; 151: 479-488
10. Feng GG, Zhou XG, Yu BM. Prevention of metastasis to liver by using 5-FU intraperitoneal chemotherapy in nude mice inoculated with human colonic cancer cells. China Natl J New Gastroenterol 1996; 2: 134-135
11. Cavaliere F, Perri P, Di Filippo F, Giannarelli D, Botti C, Cosimelli M, Tedesco M, Principi F, Laurenzi L, Cavaliere R. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000; 74: 41-44
12. Ceelen WP, Hesse U, De Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87: 1006-1015
13. Fujimura T, Yonemura Y, Nakagawara H, Kitagawa H, Fushida S, Nishimura G, Miyazaki I, Shibata K. Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. Oncol Rep 2000; 7: 809-814
14. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure. Oncology 2000; 58: 96-107
15. Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, Manns M, Klempnauer J. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 2001; 27: 286-290
16. Sobat H, Juretic A, Samija M. Combined modality therapy of rectal cancers. Ann Oncol 1999; 10: 99-103
17. Cavaliere F, Di Filippo F, Cosimelli M, Aloe L, Arcuri E, Anza M, Callopoli A, Di Lauro L, Morace E, Botti C, Natoli S, Tedesco M, Giunta S, Cavaliere R. The integrated treatment of peritoneal carcinomatosis. A preliminary experience. J Exp Clin Cancer Res 1999; 18: 151-158
18. Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Nishimura G, Miwa K, Endou Y, Tanaka M, Sasaki T. A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination. Hepatogastroenterology 1999; 46: 601-609
19. Samel S, Singal A, Becker H, Post S. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol 2000; 26: 222-226
20. Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, Budach V, Felix R, Schlag PM. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000; 48: 381-391
21. Shido A, Ohmura S, Yamamoto K, Kobayashi T, Fujimura T, Yonemura Y. Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion? World J Surg 2000; 24: 507-511
22. Abe T, Sakaguchi Y, Ohno S, Ikeda Y, Kitamura K, Maehara Y, Sugimachi K. Apoptosis and p53 overexpression in human rectal cancer; Relationship with response to hyperthermo-chemoradiotherapy. Anticancer Res 2001; 21: 2115-2120
23. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 2002; 131: 521-528
24. Zhang GQ, Qing SH, Zhou ZD, Qi DL, Hou BH. Animal experiment study of toxin of regional and system of MMC intraperitoneal hyperthermotherapy perfusion. Shijie Huaren Xiaohua Zazhi 2000; 8: 592-593.
25. Sayag-Beaujard AC, Francois Y, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 1999; 19: 1375-1382
26. Hou BH, Qing SH, Dong FY, Qi DL, Zhang GQ, Zhao F, yao XQ, Peng M. Effects of continuous hyperemia peritoneal perfusion chemotherapy on peritoneal implantation of human colonic cancer cells in nude mice. Shijie Huaren Xiaohua Zazhi 2000;8:650-653
27. Luo F, Sun JL, Ren DM, Cai D, Shen M. Effect of hyperthermia on telomerase activity and genes expression in human gastric cancer cell line. Shijie Huaren Xiaohua Zazhi 2001; 9: 1261-1264
28. Okamoto M, Tazawa K, Kawagoshi T. Maeda M, Honda T, Sakamoto T, Tsukada K. The combined effect against colon-26 cells of heat treatment and immunization with heat treated colon-26 tumour cell extract. Int J Hyperthermia 2000; 16: 263-273
29. Sinha P, Poland J, Schnolzer M, Celis JE, Lage H. Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines. Electrophoresis Electrophoresis 2001; 22: 2990-3000
30. Wang XY, Kazim L, Repasky EA, Subjeck JR, Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001; 166: 490-497
31. Han DM, Zhu XN, Huang ZG, Wang JJ, Cheng J, Fan EZ, Pian YS, Li Y, Zhang W. The observation on treatment effects of local adoptive immunotherapy in 33 cases with head and neck cancer. Zhonghua Zhongliu Zazhi 1997; 19: 454-456
32. Gravis G, Viens P, Vey N, Blaise D,Stoppa AM, Olive D,Maranichi D. Pilot study of immunotherapy with interleukin-2 after autologous stem cell transplantation in advanced breast cancers. Anticancer Res 2000; 20: 3987-3991
33. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001; 411: 380-384
34. Buzio C, Andrulli S, Santi R, Pavone L, Passalacqua R, Potenzoni D, Ferrozzi F, Giacosa R, Vaglio A. Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma. Cancer 2001; 92: 2286-2296
35. Mantovani G, Maccio A, Madeddu C, Massa E, Mudu MC, Mulas C, Gramignano G, Massidda S, Murgia V, Lusso MR, Mura L. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy. Int J Oncol 2001; 18: 383-391
36. Rosenberg SA. Progress in the development of immunotherapy for the treatment of patients with cancer. J Intern Med 2001; 250: 462-475
37. Atkins MB. Interleukin-2: Clinical applications. Semin Oncol 2002; 29: 12-17